![]() The use of auto-injectors shortens response time for administering organophosphate antidote treatment. There were no differences between injection time and occupation, receipt of prior training, wearing of personal protective equipment, or perceived ease of injection device use. ![]() There was no difference in time to administer the Mark I auto-injectors vs. The ATNAA required less time to administer than the Mark I or traditional needle/syringe devices (p <. Injection time differentials were compared using one-way analysis of variance post hoc evaluation was performed using the Scheffe test with Bonferroni correction. Subjects also completed a 14-item survey containing demographic questions, perceived ease of injection, receipt of prior training, and preferred training format for organophosphate treatment. There were 62 participants assigned to one of three groups: Mark I, ATNAA (antidote treatment nerve agent auto-injector), and traditional needle/syringe however, the results from only 56 participants could be analyzed. The study was a randomized, un-blinded design. auto-injectors in different treatment conditions. ![]() This study is intended to quantify and compare the time required to administer organophosphate antidotes using traditional equipment vs. Timing required to administer organophosphate antidotes using traditional equipment vs. Antidotes are available to counter the effects of organophosphates, but they must be administered shortly after exposure. Organophosphates may be used as weapons in chemical attacks on civilian or military populations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |